Equillium Inc (EQ) Stock News

A federal securities class action has been filed against BitGo Holdings, Inc. alleging that the company and its executives made false and misleading statements by understating risks posed by declining digital asset prices to its business. The lawsuit covers investors who purchased BTGO securities during the January 22, 2026 IPO through May 13, 2026. The deadline to seek lead plaintiff appointment is August 7, 2026.

A federal securities class action has been filed against Badger Meter, Inc. (NASDAQ: BMI) alleging that the company and its executives made false and misleading statements about strong demand and growth prospects while concealing unsustainable financial results. The lawsuit covers investors who purchased BMI stock between April 18, 2024 and April 16, 2026. The deadline to seek lead plaintiff appointment is August 3, 2026.

Faruqi & Faruqi, LLP is investigating a federal securities class action against AeroVironment, Inc. (NASDAQ: AVAV) for allegedly making false and misleading statements about its business prospects. The lawsuit covers investors who purchased AVAV stock between June 25, 2025 and March 10, 2026. The complaint alleges the company understated competition for its SCAR program contracts and overstated financial prospects. The deadline to seek lead plaintiff appointment is July 27, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Roblox Corporation, alleging the company made false and misleading statements about its organic growth potential while concealing the negative impact of its age verification rollout. The lawsuit covers investors who purchased RBLX securities between October 30, 2025 and April 30, 2026. On April 30, 2026, Roblox announced disappointing Q1 results with slashed bookings guidance (8-12%) and revealed age verification adoption impacts were far greater than previously disclosed, causing the stock to plummet 18.33% in a single day from $55.26 to $45.13 per share. The deadline to seek lead plaintiff appointment is August 7, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Calix, Inc., alleging the company made false statements about Q1 2026 margins by concealing that strong results were artificially inflated by advanced memory component purchasing. When the company disclosed on April 21, 2026 that its advanced supply had depleted and it would face rising market prices, CALX stock fell 13.98%. The deadline to seek lead plaintiff status is July 27, 2026.

A securities class action lawsuit has been filed against Globant S.A. for allegedly making false and misleading statements about its Latin American operations. The company disclosed significant failures on August 14, 2025, announcing a 2% headcount reduction (1,000 employees) and a $47.6 million restructuring charge, causing the stock to drop from $78.12 to $66.46 per share in a single day. Investors who purchased GLOB stock between February 15, 2024 and August 14, 2025 may be eligible to participate in the class action, with a June 23, 2026 deadline to seek lead plaintiff appointment.

A federal securities class action has been filed against Regencell Bioscience Holdings Limited (NASDAQ: RGC) alleging that the company and its executives made false and misleading statements by concealing vulnerability to market manipulation and regulatory risks. The DOJ launched an investigation into trading in RGC's ordinary shares, disclosed on October 31, 2025, causing the stock to fall 18.56%. Investors who purchased RGC securities between October 28, 2024 and October 31, 2025 may be eligible to participate in the lawsuit, with a June 23, 2026 deadline to seek lead plaintiff appointment.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Lucid Group, reminding investors of the July 28, 2026 deadline to seek lead plaintiff status. The lawsuit alleges that Lucid and its executives made false statements about manufacturing capabilities while concealing a supplier quality issue that disrupted Lucid Gravity deliveries. The disclosure of only 3,093 Q1 vehicles delivered, $280-284M revenue (vs. $433.8M consensus), and over $1B net loss caused significant stock price declines.

The S&P 500 closed higher by 26 basis points, but market tensions are rising as the VIXEQ-to-VIX spread hits a record 30.8, indicating elevated single-stock volatility relative to overall market volatility. This dispersion is driven by rising implied volatility in semiconductor stocks, particularly Micron, Broadcom, and IBM. Historically, such spreads have preceded significant market pullbacks. Bitcoin fell 3% and broke below a key uptrend, suggesting potential further weakness ahead.

Diluted EPS Q2 Adjusted 1 $2.03 (10%) q/q, (12%) y/y Return on equity Q2 Adjusted 1 10.2% (90 bps) q/q, (170 bps) y/y PPPT 2 Q2 Adjusted 1 $153.1MM (2%) q/q, (4%) y/y Total PCL Q2 Adjusted 1 $45.4MM +16% q/q, +50% y/y CET1 ratio 13.6% Total capital ratio 17.1% Q2 Reported $1.29 (39%) q/q, (42%) y/y Q2 Reported 6.5% (390 bps) q/q, (490 bps) y/y Q2 Reported $119.5 (19%) q/q, (23%) y/y Q2 Reported $45.4MM +16% q/q, +50% y/y Common share dividend declared $0.61/share +3% q/q, 15% y/y TORONTO , May 27, 2026 /CNW/ - EQB Inc. (TSX: EQB ) today reported earnings for the second quarter and six months ended April 30, 2026. Adjusted diluted EPS 1 : $2.03, (10%) q/q and (12%) y/y (reported $1.29) Adjusted net income 1 : $78.3 million, (8%) q/q and (17%) y/y (reported $51.3 million) Adjusted PPPT 1,2 : $153.1 million, (2%) q/q and (4%) y/y (reported $119.5 million) Adjusted ROE 1 : 10.2%, (90 bps) q/q and (170 bps) y/y (reported 6.5%) Revenue : $302.4 million, (1%) q/q and (4%) y/y (reported $302.4 million) Book value per share : $81.46, flat q/q and +1% y/y EQ Bank customers : 659,000, +4% q/q and +18% y/y Common share dividends declared : $0.61 per share, +3% q/q and +15% y/y Capital: CET1 ratio of 13.6% and total capital ratio of 17.1% "The second quarter reflected solid performance during a persistently uncertain economic environment and our team performed well against this backdrop, continuing to demonstrate operating discipline, renewed focus, and financial resilience," said Chadwick Westlake, President and CEO. "As we look ahead to the second half of the year, our business will meaningfully shift with the anticipated July 1 close of our PC Financial transaction – positioning us to serve millions of Canadians as a challenger at scale. Through a new loyalty-linked banking ecosystem, we will provide Canadians with better value, better products, more rewards and new channels, p

Olema Oncology announced a clinical trial collaboration with Bayer to evaluate OP-3136, a KAT6 inhibitor, in combination with darolutamide in approximately 36 patients with metastatic castration-resistant prostate cancer. The Phase 1b/2 study is expected to initiate in H2 2026 and represents the first clinical collaboration for OP-3136. Olema will lead the study while maintaining full global commercial rights to OP-3136, with clinical data and inventions jointly owned.

Flyte, a regional air mobility company, announced full-scale activation of its Memorial Day flight network across the Northeast corridor, deploying aircraft on high-frequency short-haul routes including NYC to Nantucket, Hamptons, and Martha's Vineyard. The company aims to capture premium travel demand during the holiday weekend surge by offering sub-one-hour flights as an alternative to congested ground travel.